CH618015A5 - - Google Patents

Download PDF

Info

Publication number
CH618015A5
CH618015A5 CH161277A CH161277A CH618015A5 CH 618015 A5 CH618015 A5 CH 618015A5 CH 161277 A CH161277 A CH 161277A CH 161277 A CH161277 A CH 161277A CH 618015 A5 CH618015 A5 CH 618015A5
Authority
CH
Switzerland
Prior art keywords
reagent
camp
cgmp
solution
reagents
Prior art date
Application number
CH161277A
Other languages
English (en)
French (fr)
Inventor
Omokazu Satoh
Junichi Takezawa
Akira Kuninaka
Miyuki Honma
Michio Ui
Original Assignee
Yamasa Shoyu Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu Kk filed Critical Yamasa Shoyu Kk
Publication of CH618015A5 publication Critical patent/CH618015A5/fr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/804Radioisotope, e.g. radioimmunoassay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/826Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH161277A 1976-02-12 1977-02-10 CH618015A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51014665A JPS5825980B2 (ja) 1976-02-12 1976-02-12 サイクリックヌクレオチドの定量法

Publications (1)

Publication Number Publication Date
CH618015A5 true CH618015A5 (de) 1980-06-30

Family

ID=11867499

Family Applications (1)

Application Number Title Priority Date Filing Date
CH161277A CH618015A5 (de) 1976-02-12 1977-02-10

Country Status (7)

Country Link
US (1) US4115538A (de)
JP (1) JPS5825980B2 (de)
CA (1) CA1092022A (de)
CH (1) CH618015A5 (de)
DE (1) DE2705897C3 (de)
FR (1) FR2341139A1 (de)
GB (1) GB1527465A (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378344A (en) * 1979-09-28 1983-03-29 Ventrex Laboratories, Inc. Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system
US4433061A (en) * 1981-06-01 1984-02-21 American Hospital Supply Corporation Radioimmunoassay for cyclic nucleotides
JPS5811857A (ja) * 1981-07-15 1983-01-22 Yamasa Shoyu Co Ltd アデノシンの定量法
US5118607A (en) * 1989-10-23 1992-06-02 Hawaii Biotechnology Group, Inc. Non-aqueous solvent specific binding protein assays
CA2238283C (en) * 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US7402400B2 (en) 2001-07-03 2008-07-22 Regents Of The University Of California Mammalian sweet taste receptors
US6686171B2 (en) 1999-05-10 2004-02-03 Tropix, Inc. Competitive chemiluminescent assay for cyclic nucleotide monophosphates
US6794156B2 (en) 1999-05-10 2004-09-21 Applera Corporation Cell growth, induction and lysis in an antibody-coated microplate for use in an ELISA
TW201006846A (en) 2000-03-07 2010-02-16 Senomyx Inc T1R taste receptor and genes encidung same
TW201022287A (en) 2001-01-03 2010-06-16 Senomyx Inc T1R taste receptors and genes encoding same
US7883856B2 (en) 2001-04-05 2011-02-08 Senomyx Inc. Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
MXPA03009580A (es) * 2001-04-20 2004-12-06 Sinai School Medicine Tir3, un receptor de sabor novedoso.
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
US6809104B2 (en) * 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
US20070135425A1 (en) * 2001-05-04 2007-06-14 Amgen Inc. Fused heterocyclic compounds
EP2327985B2 (de) 2001-06-26 2019-08-21 Senomyx, Inc. Hetero-oligomere T1R-Geschmacksrezeptoren und diese Rezeptoren exprimierende Zelllinien und deren Verwendung zur Identifizierung von Geschmacksverbindungen
CA2463553A1 (en) * 2001-10-12 2003-04-17 The Regents Of The University Of California Gastrointestinal chemosensory receptors
MXPA05004739A (es) * 2002-11-06 2005-08-02 Tularik Inc Compuestos heterociclicos fusionados.
BRPI0413324A (pt) 2003-08-06 2006-10-10 Senomyx Inc receptores de paladar hetero-oligoméricos t1r, linhas de células que expressam os ditos receptores, e compostos de paladar
US20050244810A1 (en) * 2003-09-29 2005-11-03 Egan Josephine M Taste signaling in gastrointestinal cells
ES2658859T3 (es) 2005-10-20 2018-03-12 Senomyx, Inc. Receptores del sabor dulce-umami y umami-dulce humanos quiméricos
EP2008095A1 (de) * 2006-04-20 2008-12-31 Givaudan SA Funktionelles verfahren zur identifizierung von geschmacksstoffen
US20110097741A1 (en) * 2006-04-20 2011-04-28 Jay Patrick Slack Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays
KR101356914B1 (ko) 2006-04-20 2014-01-28 지보당 에스아 단맛 강화 방법
WO2007124152A2 (en) 2006-04-21 2007-11-01 Senomyx, Inc. Comestible compositions comprising high potency savory flavorants, and processes for producing them
KR101511394B1 (ko) * 2007-01-18 2015-04-10 지보당 에스아 키메라 우마미 미각 수용체, 이를 코딩하는 핵산 및 이의 용도
KR20100016044A (ko) 2007-03-30 2010-02-12 지보당 에스아 조절제의 동정 방법
AU2008282805B2 (en) 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
CA2982520A1 (en) 2007-08-21 2009-02-26 Senomyx, Inc. Identification of human t2r receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof
WO2010037001A2 (en) 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins
DK2376101T3 (en) 2008-12-29 2016-01-18 Trevena Inc BETA-arrestin effectors AND COMPOSITIONS AND METHODS FOR USE THEREOF
EA201101524A1 (ru) 2009-04-20 2012-07-30 Элселикс Терапьютикс, Инк. Способ и композиция для лечения состояния, связанного с хемосенсорным рецептором
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
WO2011138455A1 (en) 2010-05-07 2011-11-10 Givaudan Sa Methods to identify modulators
US20130123135A1 (en) 2010-05-07 2013-05-16 Jay Patrick Slack Methods To Identify Modulators of TAS2R48 Receptors
AU2011317140A1 (en) 2010-10-19 2013-05-30 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
SG10201607085WA (en) 2011-01-07 2016-10-28 Elcelyx Therapeutics Inc Chemosensory Receptor Ligand-Based Therapies
ES2857549T3 (es) 2011-03-23 2021-09-29 Trevena Inc Ligandos de receptores de opioides y métodos para utilizar y obtener los mismos
US20130040317A1 (en) 2011-08-08 2013-02-14 The University Of North Carolina At Chapel Hill Cell lines comprising endogenous taste receptors and their uses
US9128079B2 (en) 2011-08-08 2015-09-08 The Coca-Cola Company Methods of using lung or bronchial epithelial cells to identify bitter taste modulators
AU2013215269A1 (en) 2012-01-31 2014-08-21 Trevena, Inc. Beta-arrestin effectors and compositions and methods of use thereof
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
WO2014124458A1 (en) 2013-02-11 2014-08-14 The Regents Of The University Of California Compositions and methods for treating neurodegenerative diseases
AU2014237801B2 (en) 2013-03-15 2017-08-10 Applied Food Biotechnology, Inc. Feline bitter taste receptors and methods
JP2017506235A (ja) 2014-02-07 2017-03-02 トレベナ・インコーポレイテッドTrevena, Inc. ベータ−アレスチンエフェクターの結晶性および非晶質形態
CA2939219C (en) 2014-02-11 2023-02-28 Mitokinin Llc Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
AU2015264367A1 (en) 2014-05-19 2016-12-15 Trevena, Inc. Synthesis of Beta-Arrestin Effectors
SI3344248T1 (sl) 2015-09-02 2022-07-29 Trevena, Inc. 6-členske aza-heterociklične spojine za modulacijo, ki vsebujejo delta-opioidne receptorje, metode uporabe in izdelave
EP3389657A4 (de) 2015-12-14 2019-08-07 Trevena, Inc. Verfahren zur behandlung von hyperalgesie
WO2018045369A1 (en) * 2016-09-05 2018-03-08 BellBrook Labs High-throughput screening assay
BR112019016827A2 (pt) 2017-02-17 2020-04-07 Trevena Inc compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos
CA3052479A1 (en) 2017-02-17 2018-08-23 Trevena, Inc. 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CA3067695A1 (en) 2017-06-21 2018-12-27 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
CN112858504A (zh) * 2021-01-08 2021-05-28 苏州国辰生物科技股份有限公司 一种液质联用测定生物体液样品中cGMP浓度的检测方法
WO2023154597A1 (en) 2022-02-11 2023-08-17 Firmenich Incorporated Cells expressing umami taste receptors and uses thereof

Also Published As

Publication number Publication date
DE2705897B2 (de) 1979-06-21
GB1527465A (en) 1978-10-04
DE2705897C3 (de) 1980-02-28
DE2705897A1 (de) 1977-08-18
US4115538A (en) 1978-09-19
JPS5825980B2 (ja) 1983-05-31
CA1092022A (en) 1980-12-23
FR2341139B1 (de) 1979-10-05
FR2341139A1 (fr) 1977-09-09
JPS52117418A (en) 1977-10-01

Similar Documents

Publication Publication Date Title
CH618015A5 (de)
Dixon Measurement of antibodies to insulin in serum
EP3394622B1 (de) Reagenzverdünnungsmittel
WO2015040319A1 (fr) Solution de dissociation de la vitamine d de sa protéine de liaison, procédé de détection associé et utilisation
Pacha A method for the fluorimetric determination of thioridazine (Mellaril®) or mesoridazine (Lidanil®) in Plasma
EP0022005A1 (de) Verfahren zum Trennen einer eiweissartigen Substanz mittels Affinitätsfiltrierung einer diese Substanz enthaltenden Lösung und Verwendung dieses Verfahrens für enzymatische Bestimmungen
Samanidou et al. Development of a validated HPLC method for the determination of four penicillin antibiotics in pharmaceuticals and human biological fluids
EP0311492A2 (de) Immuntestsatz und -verfahren für ganze Zellen
FR2500009A1 (fr) Procede et systeme de necessaire experimental diagnostique pour determiner quantitativement la presence de la forme isoenzymatique mb de la creatine kinase
Niemelä Acetaldehyde adducts in circulation
FR2678387A1 (fr) Procede de dosage immuno-enzymatique de la vitamine b12 et de preparation d'un echantillon pour ce dosage.
CH644455A5 (fr) Procede d'analyse quantitative des nucleotides cycliques et ensemble de reactifs pour la mise en oeuvre de ce procede.
FR2476320A1 (fr) Nouveau reactif immunologique pour la detection en tubes du facteur rhumatoide dans un echantillon biologique et procede de preparation de ce nouveau reactif
FR2763691A1 (fr) Procede ameliore d'analyse immunologique par polarisation de fluorescence
WO1999040442A1 (fr) Dosage des troponines sans interferences dues a l'heparine
EP2005181B1 (de) C4d/c4b-standard für die quantitative durchflusszytometrie humoraler transplantatabstossung
FR2537723A1 (fr) Procede et composition pour evaluer la reaction phagocytaire
EP0041019A2 (de) Aus thymischem serischem Faktor oder seinen Analoga und Derivaten hergestellte Präparate, Verfahren zu ihrer Herstellung, diese Präparate zur Verwendung als Arzneimittel, aus diesen Produkten erhaltene Isotopenindikatoren und Anwendung dieser Isotopenindikatoren in Dosierungsverfahren
FR2460482A1 (fr) Composition et procede de titrage de l'erythropoietine humaine
JP4163056B2 (ja) 血中インスリン濃度測定用添加剤組成物及びそれを含む採血管
EP3080144B1 (de) Stabilisierung von glutamat-dehydrogenase in einer wässrigen lösung
JP3663781B2 (ja) 安定化方法
SU1719974A1 (ru) Способ определени тиопентала натри в крови
Handayani NOVEL METHOD THYROID HORMONE MEASUREMENT
WO2002068961A1 (fr) Reactif destine au despitage ante-mortem d"atnc

Legal Events

Date Code Title Description
PL Patent ceased